Omega-3 maker MiAlgae strengthens team as its gears up for expansion
Pharma ingredients expert joins at pivotal time for whisky waste repurposing firm
Scotland-based MiAlgae, which repurposes whisky industry by-products to grow microalgae as a sustainable, cost-effective alternative to fish-derived omega-3 sources, has strengthened its leadership team with the appointment of Jerome Quiohilag as associate director.
Quiohilag joins MiAlgae from Veranova, a global leader in the development and manufacturing of specialist and complex active pharmaceutical ingredients (APIs) for pharma and biotech customers. At Veranova, he was responsible for overseeing the production of medicinal products, ensuring compliance with strict quality and safety standards.
At MiAlgae, Quiohilag will play a key role in scaling production capacity, enhancing manufacturing efficiency, and supporting the company’s growth plans.
Commercial scale
Last year, MiAlgae successfully reached commercial-scale production of NaturAlgae, its sustainable marine omega-3 product, at its Scottish demonstrator site at Balfron, Stirlingshire. Now, the company is preparing for the development of an industrial scale production facility in Scotland, with the first phase set for completion in 2025.
Quiohilag said he is excited to contribute to MiAlgae’s mission at a pivotal stage of expansion. “This is a unique opportunity to join a fast-growing company with a clear mission and global ambition,” he said. “I look forward to applying my expertise to scale operations and contribute to a greener, more sustainable future.”
Douglas Martin, founder and managing director of MiAlgae, said: “We’re thrilled to welcome Jerome at this exciting time for MiAlgae. His expertise will be crucial as we scale up to meet growing demand and continue driving biotech innovation.”
